Diferencia entre revisiones de «Atorvastatin»
| Línea 35: | Línea 35: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Hepatotoxicity | |||
*Rhabdomyolysis | |||
===Common=== | ===Common=== | ||
*Arthralgias | |||
*Dyspepsia | |||
*Nausea | |||
*UTI | |||
*Insomnia | |||
==Pharmacology== | ==Pharmacology== | ||
Revisión del 15:44 20 ago 2023
Administration
- Type: Statins (HMG-CoA Reductase Inhibitor)
- Dosage Forms:
- Routes of Administration: PO
- Common Trade Names: Lipitor
Adult Dosing
Hyperlipidemia
- Moderate Intensity: 10-20 mg PO daily
- High Intensity: 40-80 mg PO daily
Acute Coronary Syndrome
- 80 mg PO (Single dose prior to PCI)
Pediatric Dosing
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hepatotoxicity
- Rhabdomyolysis
Common
- Arthralgias
- Dyspepsia
- Nausea
- UTI
- Insomnia
Pharmacology
- Half-life:
- Metabolism:
- Excretion: